Literature DB >> 28988323

Analysis of NOD-like receptor NLRP1 in multiple sclerosis families.

Cecily Q Bernales1, Mary Encarnacion1, Maria G Criscuoli1, Irene M Yee1, Anthony L Traboulsee2, A Dessa Sadovnick1,2, Carles Vilariño-Güell3.   

Abstract

The implementation of exome sequencing technologies has started to unravel the genetic etiology of familial multiple sclerosis (MS). A homozygote p.G587S mutation in NLRP1 has been suggested as potentially causative for the onset of MS in an affected sibling pair, who later developed malignant melanoma. To validate the proposed role of recessive NLRP1 mutations in the pathological mechanisms of MS, we examined exome sequencing data from 326 MS patients from Canada for the identification of NLRP1 missense and nonsense variants. This analysis did not identify the previously described p.G587S mutation; however, three patients with potential NLRP1 compound heterozygote mutations were observed. Haplotype and segregation analyses indicate that the variants observed in these patients were inherited in cis, and do not segregate with disease within families. Thus, the analysis of MS patients from Canada failed to identify potentially pathogenic mutations in NLRP1, including the previously described p.G587S mutation. Further studies are necessary to confirm a role of NLRP1 in the pathophysiology of MS.

Entities:  

Keywords:  Familial; Multiple sclerosis; Mutation; NLRP1; NOD-like receptors

Mesh:

Substances:

Year:  2017        PMID: 28988323     DOI: 10.1007/s00251-017-1034-2

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  16 in total

Review 1.  The inflammasomes and autoinflammatory syndromes.

Authors:  Lori Broderick; Dominic De Nardo; Bernardo S Franklin; Hal M Hoffman; Eicke Latz
Journal:  Annu Rev Pathol       Date:  2014-11-19       Impact factor: 23.472

2.  STX6 rs1411478 is not associated with increased risk of Parkinson's disease.

Authors:  Joanne Trinh; Carles Vilariño-Güell; Alan Donald; Brinda Shah; Irene Yu; Chelsea Szu-Tu; Jan O Aasly; Ruey-Meei Wu; Faycal Hentati; Ali H Rajput; Alex Rajput; Matthew J Farrer
Journal:  Parkinsonism Relat Disord       Date:  2013-02-14       Impact factor: 4.891

3.  Common genetic etiology between "multiple sclerosis-like" single-gene disorders and familial multiple sclerosis.

Authors:  Anthony L Traboulsee; A Dessa Sadovnick; Mary Encarnacion; Cecily Q Bernales; Irene M Yee; Maria G Criscuoli; Carles Vilariño-Güell
Journal:  Hum Genet       Date:  2017-03-23       Impact factor: 4.132

Review 4.  Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury.

Authors:  Juan Pablo de Rivero Vaccari; W Dalton Dietrich; Robert W Keane
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-08       Impact factor: 6.200

Review 5.  Modulating inflammation and neuroprotection in multiple sclerosis.

Authors:  Heather Yong; Gabrielle Chartier; Jacqueline Quandt
Journal:  J Neurosci Res       Date:  2017-06-05       Impact factor: 4.164

6.  Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.

Authors:  Anthony L Traboulsee; Cecily Q Bernales; Jay P Ross; Joshua D Lee; A Dessa Sadovnick; Carles Vilariño-Güell
Journal:  Neurogenetics       Date:  2014-04-26       Impact factor: 2.660

Review 7.  Recognition of bacteria by inflammasomes.

Authors:  Jakob von Moltke; Janelle S Ayres; Eric M Kofoed; Joseph Chavarría-Smith; Russell E Vance
Journal:  Annu Rev Immunol       Date:  2012-11-26       Impact factor: 28.527

Review 8.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

9.  Identification of rare genetic variation of NLRP1 gene in familial multiple sclerosis.

Authors:  Ales Maver; Polona Lavtar; Smiljana Ristić; Sanja Stopinšek; Saša Simčič; Keli Hočevar; Juraj Sepčić; Jelena Drulović; Tatjana Pekmezović; Ivana Novaković; Hodžić Alenka; Gorazd Rudolf; Saša Šega; Nada Starčević-Čizmarević; Anja Palandačić; Gordana Zamolo; Miljenko Kapović; Tina Likar; Borut Peterlin
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

10.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

View more
  8 in total

1.  NLRP1 promotes TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.

Authors:  Jing Zong; Hao Zhang; Fang-Fang Li; Kai Liang; Jia-Li Liu; Lu-Hong Xu; Wen-Hao Qian
Journal:  J Mol Histol       Date:  2018-08-18       Impact factor: 2.611

Review 2.  NLR-Dependent Regulation of Inflammation in Multiple Sclerosis.

Authors:  Marjan Gharagozloo; Katsiaryna V Gris; Tara Mahvelati; Abdelaziz Amrani; John R Lukens; Denis Gris
Journal:  Front Immunol       Date:  2018-01-18       Impact factor: 7.561

3.  Multiple Sclerosis patients carry an increased burden of exceedingly rare genetic variants in the inflammasome regulatory genes.

Authors:  Lovro Vidmar; Ales Maver; Jelena Drulović; Juraj Sepčić; Ivana Novaković; Smiljana Ristič; Saša Šega; Borut Peterlin
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

4.  Amentoflavone Affects Epileptogenesis and Exerts Neuroprotective Effects by Inhibiting NLRP3 Inflammasome.

Authors:  Shikuo Rong; Ding Wan; Yayun Fan; Shenhai Liu; Kuisheng Sun; Junming Huo; Peng Zhang; Xinxiao Li; Xiaoliang Xie; Feng Wang; Tao Sun
Journal:  Front Pharmacol       Date:  2019-07-30       Impact factor: 5.810

Review 5.  Predicting Multiple Sclerosis: Challenges and Opportunities.

Authors:  Luke Hone; Gavin Giovannoni; Ruth Dobson; Benjamin Meir Jacobs
Journal:  Front Neurol       Date:  2022-02-08       Impact factor: 4.086

Review 6.  Supramolecular organizing centers at the interface of inflammation and neurodegeneration.

Authors:  Petra Sušjan-Leite; Taja Železnik Ramuta; Elvira Boršić; Sara Orehek; Iva Hafner-Bratkovič
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

Review 7.  Pattern Recognition Receptors in Multiple Sclerosis and Its Animal Models.

Authors:  M Elizabeth Deerhake; Debolina D Biswas; William E Barclay; Mari L Shinohara
Journal:  Front Immunol       Date:  2019-11-12       Impact factor: 7.561

Review 8.  Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets.

Authors:  Vaidya Govindarajan; Juan Pablo de Rivero Vaccari; Robert W Keane
Journal:  J Neuroinflammation       Date:  2020-09-02       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.